West Pharmaceutical Services (WST) Goodwill & Intangibles (2009 - 2026)

West Pharmaceutical Services has disclosed Goodwill & Intangibles across 18 years of filings, most recently posting $116.2 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $116.2 million, down 1.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $116.2 million (down 1.11% YoY), and the FY2025 annual result was $117.6 million, up 0.68% from the prior year.
• Goodwill & Intangibles came in at $116.2 million for Q1 2026 at West Pharmaceutical Services, down from $117.6 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $130.6 million in Q1 2022 to a low of $116.2 million in Q1 2026.
• The 5-year median for Goodwill & Intangibles is $121.5 million (2024), against an average of $121.9 million.
• Across the five-year window, Goodwill & Intangibles retreated 9.56% in 2022 and increased 0.68% in 2025, its largest moves.
• West Pharmaceutical Services' Goodwill & Intangibles stood at $125.7 million in 2022, then decreased by 1.67% to $123.6 million in 2023, then retreated by 5.5% to $116.8 million in 2024, then advanced by 0.68% to $117.6 million in 2025, then retreated by 1.19% to $116.2 million in 2026.
• The last three Goodwill & Intangibles figures came in at $116.2 million (Q1 2026), $117.6 million (Q4 2025), and $119.5 million (Q3 2025), per Business Quant data.